Tag: kidney transplant market trends

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Kidney Transplant Market Expansion From $6.74 Billion In 2026 To $8.3 Billion In 2030

The market for kidney transplants has experienced robust expansion. Projections indicate a rise from $6.42 billion in 2025 to $6.74 billion by 2026, reflecting a compound annual growth rate of 5.0%. Factors fueling this expansion during the preceding period include the increasing prevalence of end-stage renal disease, the inherent limitations of dialysis over extended durations, the demonstrable success of transplant procedures, enhancements in transplant facility capabilities, and a greater understanding of the advantages offered by transplantation.

The kidney transplant sector is poised for significant expansion in the coming years, with projections indicating a market valuation reaching $8.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.4%. This anticipated expansion over the forecast period stems from a confluence of factors including escalating demand for organ transplantation, pioneering advancements in immunosuppressive drug treatments, a greater acceptance of organs from expanded criteria donors, augmented investments in transplant-related research, and subsequent enhancements in post-transplant survival rates. Key developments anticipated during this timeframe involve a discernible shift favoring kidney transplantation as a preferred treatment over sustained dialysis, a broader implementation of living-donor and paired kidney exchange initiatives, heightened attention on meticulous post-transplant patient surveillance and care, an increase in kidney transplant procedures for pediatric patients, and the attainment of superior outcomes through sophisticated immunosuppressive regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

Kidney Transplant Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of kidney-related ailments and the occurrence of kidney failure are anticipated to stimulate advancements within the kidney transplant sector. Kidney disorders and failure signify conditions where the kidneys cease to operate effectively, thereby losing their capacity to regulate bodily chemical balances and eliminate waste products and excess fluid from the bloodstream. Consequently, kidney failure often creates a demand for transplants to reinstate renal functionality and tackle the root causes of these conditions. Illustrating this trend, the American Kidney Fund, a US charitable entity, reported in 2023 that approximately 37 million individuals in the United States were affected by kidney disease, underscoring how the escalation of kidney problems and failure is a key factor fueling the expansion of the kidney transplant market.

Kidney Transplant Market Segments: Where Are The Largest Growth Opportunities?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

Kidney Transplant Market Industry Trends: What Changes Are Reshaping Demand?

Leading players within the kidney transplant sector are actively pursuing innovative advancements, specifically portable hypothermic perfusion systems, with the primary goals of extending the lifespan of donor kidneys, ensuring superior organ preservation throughout transit, and minimizing the number of organs that go unused. Portable hypothermic perfusion systems function as specialized medical equipment that circulates a chilled, oxygen-rich preservation fluid consistently through a donated kidney. This active circulation sustains the organ’s metabolic activity and tissue health, offering a distinct advantage over conventional static cold storage methods where organs are simply kept on ice without any active fluid movement. Illustrating this trend, Paragonix Technologies, a firm based in the United States that manufactures medical devices, obtained clearance from the U.S. Food and Drug Administration (FDA) in January 2025 for its KidneyVault Portable Renal Perfusion System. This particular device marks a substantial leap forward in kidney preservation technology, providing a completely mobile solution for continuous hypothermic perfusion from the initial organ retrieval all the way to the transplantation procedure. It facilitates ongoing, immediate oversight of crucial perfusion indicators like flow rate, pressure levels, and temperature, empowering medical professionals to preserve peak organ quality from the moment of procurement until implantation. This pioneering development contributes to more reliable preservation outcomes, mitigates potential complications linked to older static cold storage techniques, and underscores the increasing drive towards creating cutting-edge technologies designed to broaden the availability of transplantable organs and enhance patient results.

Kidney Transplant Market Major Participants And Competitive Dynamics

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Access The Complete Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Kidney Transplant Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the kidney transplant market in 2025.Europeis expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Kidney Transplant Market Expansion From $6.74 Billion In 2026 To $8.3 Billion In 2030

The market for kidney transplants has experienced robust expansion. Projections indicate a rise from $6.42 billion in 2025 to $6.74 billion by 2026, reflecting a compound annual growth rate of 5.0%. Factors fueling this expansion during the preceding period include the increasing prevalence of end-stage renal disease, the inherent limitations of dialysis over extended durations, the demonstrable success of transplant procedures, enhancements in transplant facility capabilities, and a greater understanding of the advantages offered by transplantation.

The kidney transplant sector is poised for significant expansion in the coming years, with projections indicating a market valuation reaching $8.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.4%. This anticipated expansion over the forecast period stems from a confluence of factors including escalating demand for organ transplantation, pioneering advancements in immunosuppressive drug treatments, a greater acceptance of organs from expanded criteria donors, augmented investments in transplant-related research, and subsequent enhancements in post-transplant survival rates. Key developments anticipated during this timeframe involve a discernible shift favoring kidney transplantation as a preferred treatment over sustained dialysis, a broader implementation of living-donor and paired kidney exchange initiatives, heightened attention on meticulous post-transplant patient surveillance and care, an increase in kidney transplant procedures for pediatric patients, and the attainment of superior outcomes through sophisticated immunosuppressive regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

Kidney Transplant Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of kidney-related ailments and the occurrence of kidney failure are anticipated to stimulate advancements within the kidney transplant sector. Kidney disorders and failure signify conditions where the kidneys cease to operate effectively, thereby losing their capacity to regulate bodily chemical balances and eliminate waste products and excess fluid from the bloodstream. Consequently, kidney failure often creates a demand for transplants to reinstate renal functionality and tackle the root causes of these conditions. Illustrating this trend, the American Kidney Fund, a US charitable entity, reported in 2023 that approximately 37 million individuals in the United States were affected by kidney disease, underscoring how the escalation of kidney problems and failure is a key factor fueling the expansion of the kidney transplant market.

Kidney Transplant Market Segments: Where Are The Largest Growth Opportunities?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

Kidney Transplant Market Industry Trends: What Changes Are Reshaping Demand?

Leading players within the kidney transplant sector are actively pursuing innovative advancements, specifically portable hypothermic perfusion systems, with the primary goals of extending the lifespan of donor kidneys, ensuring superior organ preservation throughout transit, and minimizing the number of organs that go unused. Portable hypothermic perfusion systems function as specialized medical equipment that circulates a chilled, oxygen-rich preservation fluid consistently through a donated kidney. This active circulation sustains the organ’s metabolic activity and tissue health, offering a distinct advantage over conventional static cold storage methods where organs are simply kept on ice without any active fluid movement. Illustrating this trend, Paragonix Technologies, a firm based in the United States that manufactures medical devices, obtained clearance from the U.S. Food and Drug Administration (FDA) in January 2025 for its KidneyVault Portable Renal Perfusion System. This particular device marks a substantial leap forward in kidney preservation technology, providing a completely mobile solution for continuous hypothermic perfusion from the initial organ retrieval all the way to the transplantation procedure. It facilitates ongoing, immediate oversight of crucial perfusion indicators like flow rate, pressure levels, and temperature, empowering medical professionals to preserve peak organ quality from the moment of procurement until implantation. This pioneering development contributes to more reliable preservation outcomes, mitigates potential complications linked to older static cold storage techniques, and underscores the increasing drive towards creating cutting-edge technologies designed to broaden the availability of transplantable organs and enhance patient results.

Kidney Transplant Market Major Participants And Competitive Dynamics

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Access The Complete Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Kidney Transplant Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the kidney transplant market in 2025.Europeis expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Kidney Transplant Market Expansion From $6.74 Billion In 2026 To $8.3 Billion In 2030

The market for kidney transplants has experienced robust expansion. Projections indicate a rise from $6.42 billion in 2025 to $6.74 billion by 2026, reflecting a compound annual growth rate of 5.0%. Factors fueling this expansion during the preceding period include the increasing prevalence of end-stage renal disease, the inherent limitations of dialysis over extended durations, the demonstrable success of transplant procedures, enhancements in transplant facility capabilities, and a greater understanding of the advantages offered by transplantation.

The kidney transplant sector is poised for significant expansion in the coming years, with projections indicating a market valuation reaching $8.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.4%. This anticipated expansion over the forecast period stems from a confluence of factors including escalating demand for organ transplantation, pioneering advancements in immunosuppressive drug treatments, a greater acceptance of organs from expanded criteria donors, augmented investments in transplant-related research, and subsequent enhancements in post-transplant survival rates. Key developments anticipated during this timeframe involve a discernible shift favoring kidney transplantation as a preferred treatment over sustained dialysis, a broader implementation of living-donor and paired kidney exchange initiatives, heightened attention on meticulous post-transplant patient surveillance and care, an increase in kidney transplant procedures for pediatric patients, and the attainment of superior outcomes through sophisticated immunosuppressive regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

Kidney Transplant Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of kidney-related ailments and the occurrence of kidney failure are anticipated to stimulate advancements within the kidney transplant sector. Kidney disorders and failure signify conditions where the kidneys cease to operate effectively, thereby losing their capacity to regulate bodily chemical balances and eliminate waste products and excess fluid from the bloodstream. Consequently, kidney failure often creates a demand for transplants to reinstate renal functionality and tackle the root causes of these conditions. Illustrating this trend, the American Kidney Fund, a US charitable entity, reported in 2023 that approximately 37 million individuals in the United States were affected by kidney disease, underscoring how the escalation of kidney problems and failure is a key factor fueling the expansion of the kidney transplant market.

Kidney Transplant Market Segments: Where Are The Largest Growth Opportunities?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

Kidney Transplant Market Industry Trends: What Changes Are Reshaping Demand?

Leading players within the kidney transplant sector are actively pursuing innovative advancements, specifically portable hypothermic perfusion systems, with the primary goals of extending the lifespan of donor kidneys, ensuring superior organ preservation throughout transit, and minimizing the number of organs that go unused. Portable hypothermic perfusion systems function as specialized medical equipment that circulates a chilled, oxygen-rich preservation fluid consistently through a donated kidney. This active circulation sustains the organ’s metabolic activity and tissue health, offering a distinct advantage over conventional static cold storage methods where organs are simply kept on ice without any active fluid movement. Illustrating this trend, Paragonix Technologies, a firm based in the United States that manufactures medical devices, obtained clearance from the U.S. Food and Drug Administration (FDA) in January 2025 for its KidneyVault Portable Renal Perfusion System. This particular device marks a substantial leap forward in kidney preservation technology, providing a completely mobile solution for continuous hypothermic perfusion from the initial organ retrieval all the way to the transplantation procedure. It facilitates ongoing, immediate oversight of crucial perfusion indicators like flow rate, pressure levels, and temperature, empowering medical professionals to preserve peak organ quality from the moment of procurement until implantation. This pioneering development contributes to more reliable preservation outcomes, mitigates potential complications linked to older static cold storage techniques, and underscores the increasing drive towards creating cutting-edge technologies designed to broaden the availability of transplantable organs and enhance patient results.

Kidney Transplant Market Major Participants And Competitive Dynamics

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Access The Complete Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Kidney Transplant Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the kidney transplant market in 2025.Europeis expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Kidney Transplant Market?

The kidney transplant market size has exhibited substantial growth in recent years. It is projected to expand from $6.42 billion in 2025 to $6.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.0%. The historical increase in this market can be attributed to the rising occurrence of end-stage kidney disease, the restricted long-term efficacy of dialysis, the proven success rates of kidney transplantation, the development of transplant center infrastructure, and greater understanding of the benefits of transplantation.

The kidney transplant market is anticipated to experience robust expansion over the next few years. It is projected to achieve a size of $8.31 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.4%. The expected growth during this period stems from the increasing demand for organ transplantation, developments in immunosuppressive drug therapies, a rise in the use of expanded criteria donors, greater investment in transplant research, and improved post-transplant survival rates. Noteworthy trends for the forecast period include a growing preference for kidney transplant over long-term dialysis, increasing adoption of living-donor and paired kidney exchange programs, an enhanced focus on post-transplant patient monitoring and care, the expansion of pediatric kidney transplant procedures, and better outcomes achieved through advanced immunosuppressive protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

What Core Drivers Are Transforming The Kidney Transplant Market?

The increasing occurrence of renal disorders and kidney failure is projected to stimulate the expansion of the kidney transplant market moving forward. Renal disorder and kidney failure are conditions where the kidneys stop working, becoming unable to balance bodily chemicals or remove waste and surplus water from the blood. Kidney transplants are required for renal failure to regain kidney function and address its underlying causes. For instance, in 2023, as reported by the American Kidney Fund, a US-based non-profit organization, 37 million Americans had kidney disease. Thus, the rising incidence of renal disorders and kidney failure is driving the growth of the kidney transplant market.

What Are The Core Segment Classifications In The Kidney Transplant Market?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

Which Trends Are Influencing The Direction Of The Kidney Transplant Market?

Companies operating in the kidney transplant market are concentrating on creating sophisticated solutions, such as portable hypothermic perfusion systems, to boost donor kidney viability, enhance organ preservation during transit, and lower organ discard rates. This medical device works by continuously circulating a cold, oxygenated preservation solution through a donor kidney, thereby sustaining its metabolism and tissue viability, a method that contrasts with conventional static cold storage where organs are merely placed on ice without active perfusion. For instance, in January 2025, Paragonix Technologies, a U.S.-based medical device company, obtained U.S. Food and Drug Administration (FDA) clearance for its KidneyVault Portable Renal Perfusion System. This device marks a substantial improvement in kidney preservation, offering a completely mobile platform for comprehensive hypothermic perfusion throughout organ transportation. It allows for constant, real-time tracking of critical perfusion parameters, including flow, pressure, and temperature, assisting clinicians in preserving peak organ quality from retrieval to transplantation. This innovation contributes to more consistent preservation, mitigates risks linked to traditional static cold storage, and demonstrates increasing progress in developing future technologies designed to enhance transplant readiness and better patient outcomes.

Which Organizations Are Operating Within The Kidney Transplant Market?

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Access The Complete Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Which Region Accounts For The Highest Share Of The Kidney Transplant Market?

North America was the largest region in the kidney transplant market in 2025.Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Kidney Transplant Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10707&type=smp

Browse Through More Reports Similar to the Global Kidney Transplant Market 2026, By The Business Research Company

Heart Transplant Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Kidney Dialysis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report

Artificial Kidney Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Kidney Transplant Market Grow Between 2026 And 2030?

The kidney transplant market has experienced significant growth in recent years. This market is expected to expand from $6.42 billion in 2025 to $6.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.0%. The historical increase can be attributed to several factors including the rising prevalence of end-stage kidney disease, the limited long-term efficacy of dialysis, the established success rates of kidney transplantation, the development of transplant center infrastructure, and greater awareness of the benefits of transplantation.

The kidney transplant market size is projected to experience robust expansion over the coming years. This market is set to reach $8.31 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this anticipated growth include an increasing need for organ transplantation, developments in immunosuppressive drug treatments, greater use of expanded criteria donors, increased funding for transplant research, and enhanced post-transplant survival rates. Key trends during this forecast period encompass a rising inclination towards kidney transplantation instead of prolonged dialysis, a greater uptake of living-donor and paired kidney exchange initiatives, an intensifying focus on patient monitoring and care following transplantation, an increase in pediatric kidney transplant operations, and better results achieved through sophisticated immunosuppressive protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

What Key Factors Are Shaping The Kidney Transplant Market Landscape?

An expected increase in the occurrence of renal disorders and kidney failure is set to boost the expansion of the kidney transplant market moving forward. Renal disorder and kidney failure refer to conditions where the kidneys cease to operate, making them unable to balance bodily chemicals or remove waste and surplus water from the blood. Kidney transplants are necessary in cases of renal failure to restore kidney function and address the underlying reasons for the condition. For instance, in 2023, data from the American Kidney Fund, a US-based non-profit organization, revealed that 37 million Americans have kidney disease. Therefore, the rising prevalence of renal disorders and kidney failure is a significant driver for the growth of the kidney transplant market.

What Are The Key Segment Divisions In The Kidney Transplant Market Segment Structure?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

What Market Trends Are Affecting The Kidney Transplant Market?

Leading firms within the kidney transplant sector are prioritizing the creation of sophisticated solutions, including portable hypothermic perfusion systems. These systems are designed to boost donor kidney viability, optimize organ preservation during transit, and decrease organ discard rates. Such a system functions as a medical device by constantly moving a chilled, oxygenated preservation liquid through a donor kidney, thereby sustaining its metabolic processes and tissue health. This differs significantly from conventional static cold storage, which involves simply placing organs on ice without any active fluid circulation. An example of this progress occurred in January 2025, when Paragonix Technologies, a medical device company based in the U.S., secured clearance from the U.S. Food and Drug Administration (FDA) for its KidneyVault Portable Renal Perfusion System. This particular device marks a substantial step forward in kidney preservation, providing a completely mobile platform for continuous hypothermic perfusion throughout the entire organ transportation process. It allows for uninterrupted, real-time tracking of vital perfusion metrics like flow, pressure, and temperature, thereby assisting clinicians in preserving prime organ quality from the moment of retrieval up to transplantation. This innovation contributes to greater consistency in preservation, mitigates the dangers linked to conventional static cold storage, and demonstrates increasing impetus in developing future-generation technologies focused on expanding transplant readiness and enhancing patient results.

Which Organizations Are Engaged In The Kidney Transplant Market?

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Get The Full Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Where Is The Kidney Transplant Market Most Concentrated Geographically?

North America was the largest region in the kidney transplant market in 2025.Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Kidney Transplant Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Browse Through More Reports Similar to the Global Kidney Transplant Market 2026, By The Business Research Company

Heart Transplant Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Kidney Dialysis Market Report

https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report

Artificial Kidney Market Report

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model